Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delia Silverio

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Patient Preference and Adherence|November 23, 2018
Patient adherence, compliance, and perspectives on evolocumab for the management of resistant hypercholesterolemiaConstantine E Kosmas, Delia Silverio, Julio Ovalle, et al.
Annals of Translational Medicine|January 4, 2019
Role of spironolactone in the treatment of heart failure with preserved ejection fractionConstantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
World Journal of Cardiology|December 5, 2019
Novel lipid-modifying therapies addressing unmet needs in cardiovascular diseaseConstantine E Kosmas, Andreas Sourlas, Delia Silverio, et al.
Annals of Translational Medicine|September 27, 2019
Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effectsPeter D Montan, Andreas Sourlas, Jiohanna Olivero, et al.
Drugs in Context|December 6, 2018
Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitusConstantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Drugs in Context|September 15, 2018
Primary genetic disorders affecting high density lipoprotein (HDL)Constantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Annals of Translational Medicine|June 4, 2019
Anti-inflammatory therapy for cardiovascular diseaseConstantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Clinical Medicine Insights. Endocrinology and Diabetes|August 8, 2018
The Impact of Insulin Resistance and Chronic Kidney Disease on Inflammation and Cardiovascular DiseaseConstantine E Kosmas, Delia Silverio, Christiana Tsomidou, et al.
Diseases (Basel, Switzerland)|July 18, 2018
Inclisiran: A New Promising Agent in the Management of HypercholesterolemiaConstantine E Kosmas, Alba Muñoz Estrella, Andreas Sourlas, et al.
Drugs in Context|September 27, 2019
Therapeutic management of hyperlipoproteinemia (a)Constantine E Kosmas, Andreas Sourlas, Gordon Mallarkey, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Patient Preference and Adherence|November 23, 2018
Patient adherence, compliance, and perspectives on evolocumab for the management of resistant hypercholesterolemiaConstantine E Kosmas, Delia Silverio, Julio Ovalle, et al.
Annals of Translational Medicine|January 4, 2019
Role of spironolactone in the treatment of heart failure with preserved ejection fractionConstantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
World Journal of Cardiology|December 5, 2019
Novel lipid-modifying therapies addressing unmet needs in cardiovascular diseaseConstantine E Kosmas, Andreas Sourlas, Delia Silverio, et al.
Annals of Translational Medicine|September 27, 2019
Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effectsPeter D Montan, Andreas Sourlas, Jiohanna Olivero, et al.
Drugs in Context|December 6, 2018
Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitusConstantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Drugs in Context|September 15, 2018
Primary genetic disorders affecting high density lipoprotein (HDL)Constantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Annals of Translational Medicine|June 4, 2019
Anti-inflammatory therapy for cardiovascular diseaseConstantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Clinical Medicine Insights. Endocrinology and Diabetes|August 8, 2018
The Impact of Insulin Resistance and Chronic Kidney Disease on Inflammation and Cardiovascular DiseaseConstantine E Kosmas, Delia Silverio, Christiana Tsomidou, et al.
Diseases (Basel, Switzerland)|July 18, 2018
Inclisiran: A New Promising Agent in the Management of HypercholesterolemiaConstantine E Kosmas, Alba Muñoz Estrella, Andreas Sourlas, et al.
Drugs in Context|September 27, 2019
Therapeutic management of hyperlipoproteinemia (a)Constantine E Kosmas, Andreas Sourlas, Gordon Mallarkey, et al.
Pageof 1